Utility of cerebrovascular imaging biomarkers to detect cerebral amyloidosis
View ORCID ProfileMatthew D. Howe, Megan R. Caruso, Masood Manoochehri, Zachary J. Kunicki, Sheina Emrani, James L. Rudolph, Edward D. Huey, Stephen P. Salloway, Hwamee Oh, the Alzheimer’s Disease Neuroimaging Initiative
doi: https://doi.org/10.1101/2024.05.28.24308056
Matthew D. Howe
1Butler Hospital Memory & Aging Program; 345 Blackstone Boulevard, Providence, RI, 02906, USA
2Department of Psychiatry and Human Behavior, Brown University; 345 Blackstone Boulevard, Providence, RI, 02906, USA
MD, PhDMegan R. Caruso
1Butler Hospital Memory & Aging Program; 345 Blackstone Boulevard, Providence, RI, 02906, USA
BA, BSMasood Manoochehri
1Butler Hospital Memory & Aging Program; 345 Blackstone Boulevard, Providence, RI, 02906, USA
BAZachary J. Kunicki
2Department of Psychiatry and Human Behavior, Brown University; 345 Blackstone Boulevard, Providence, RI, 02906, USA
PhDSheina Emrani
3University of Pennsylvania Perelman School of Medicine; 3400 Civic Center Blvd, Philadelphia, PA, 19014, USA
PhDJames L. Rudolph
4Center of Innovation in Long-Term Services and Supports, Providence VA Medical Center; 830 Chalkstone Ave, Providence, RI, 02908, USA
5Department of Medicine, The Warren Alpert Medical School of Brown University; 222 Richmond Street, Providence, Rhode Island, 02903, USA
MDEdward D. Huey
1Butler Hospital Memory & Aging Program; 345 Blackstone Boulevard, Providence, RI, 02906, USA
2Department of Psychiatry and Human Behavior, Brown University; 345 Blackstone Boulevard, Providence, RI, 02906, USA
MDStephen P. Salloway
1Butler Hospital Memory & Aging Program; 345 Blackstone Boulevard, Providence, RI, 02906, USA
2Department of Psychiatry and Human Behavior, Brown University; 345 Blackstone Boulevard, Providence, RI, 02906, USA
MD, MSHwamee Oh
2Department of Psychiatry and Human Behavior, Brown University; 345 Blackstone Boulevard, Providence, RI, 02906, USA
PhDArticle usage
Posted May 28, 2024.
Utility of cerebrovascular imaging biomarkers to detect cerebral amyloidosis
Matthew D. Howe, Megan R. Caruso, Masood Manoochehri, Zachary J. Kunicki, Sheina Emrani, James L. Rudolph, Edward D. Huey, Stephen P. Salloway, Hwamee Oh, the Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2024.05.28.24308056; doi: https://doi.org/10.1101/2024.05.28.24308056
Utility of cerebrovascular imaging biomarkers to detect cerebral amyloidosis
Matthew D. Howe, Megan R. Caruso, Masood Manoochehri, Zachary J. Kunicki, Sheina Emrani, James L. Rudolph, Edward D. Huey, Stephen P. Salloway, Hwamee Oh, the Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2024.05.28.24308056; doi: https://doi.org/10.1101/2024.05.28.24308056
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (714)
- Anesthesia (209)
- Cardiovascular Medicine (2986)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12846)
- Forensic Medicine (12)
- Gastroenterology (839)
- Genetic and Genomic Medicine (4652)
- Geriatric Medicine (428)
- Health Economics (735)
- Health Informatics (2960)
- Health Policy (1076)
- Hematology (394)
- HIV/AIDS (938)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4441)
- Nursing (239)
- Nutrition (653)
- Oncology (2310)
- Ophthalmology (655)
- Orthopedics (260)
- Otolaryngology (328)
- Pain Medicine (285)
- Palliative Medicine (85)
- Pathology (504)
- Pediatrics (1205)
- Primary Care Research (506)
- Public and Global Health (7038)
- Radiology and Imaging (1557)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (387)
- Surgery (494)
- Toxicology (60)
- Transplantation (213)
- Urology (186)